Testicular Cancer Treatment

Testis-Sparing Surgery (selected cases)

Organ-Preserving Resection of Testicular Tumour in Selected Patients

45–90 min PROCEDURE
Day Care / 1 Day HOSPITAL STAY
>90% local SUCCESS RATE
1–2 Weeks RECOVERY

What is Testis-Sparing Surgery (selected cases)?

Testis-Sparing Surgery (TSS) is performed in highly selected patients with testicular tumours where organ preservation is feasible without compromising oncological outcomes. Indications include bilateral tumours, tumour in a solitary testis, synchronous bilateral tumours, or small tumours (<2 cm) in patients with normal contralateral testis. Intra-operative ultrasound guides complete tumour excision with clear margins while preserving residual normal testicular tissue. The procedure is performed under general or spinal anaesthesia with a hospital stay of Day Care / 1 Day. Success rates reach >90% local control in appropriately selected patients at experienced centres.

Patients with bilateral testicular tumours, tumour in a solitary testis, small peripheral tumours (<2 cm) in patients requesting organ preservation with normal contralateral testis. Patients must be adequately fit for anaesthesia and free from active systemic infection before proceeding.

How the Procedure Works

1

Inguinal Access & Cord Control

An inguinal incision is made and the spermatic cord controlled with a soft sling at the internal ring before testicular delivery.

2

Intraoperative Ultrasound

A sterile intraoperative ultrasound probe is applied to the testis to precisely delineate the tumour margins and guide excision planning.

3

Tumour Excision

The tunica albuginea is incised over the tumour and the lesion excised with a 3–5 mm margin of normal parenchyma.

4

Frozen Section Assessment

Multiple biopsies from the excision bed are sent for immediate intraoperative frozen section to confirm clear margins.

5

Closure & Adjuvant Planning

The tunica albuginea is closed with absorbable sutures and the testis replaced in the scrotum; adjuvant radiotherapy planned if GCNIS identified.

Outcomes

45–90 minDURATION
Day Care / 1 DayHOSPITAL STAY
>90% localSUCCESS RATE
1–2 WeeksFULL RECOVERY

Who Needs This Treatment?

  • Men with bilateral synchronous testicular tumours where bilateral orchidectomy would cause androgen deficiency.
  • Patients with a solitary testis from prior contralateral orchidectomy requiring organ preservation.
  • Those with small (<2 cm) testicular lesions with normal contralateral testis requesting organ preservation.
  • Men with bilateral metachronous tumours where the first side has already been removed.
  • Patients who strongly wish to avoid testosterone replacement therapy.
  • Those in specialised centres where intraoperative ultrasound and frozen section are available.
"

"Testis-sparing surgery, when correctly indicated, allows us to cure testicular cancer while preserving hormonal and reproductive function. In a young man with bilateral disease, it can be truly life-changing."

— — Dr. Vipin Reddy, Consultant Urologist, Andrologist & Renal Transplant Surgeon

Common Questions

Frequently Asked

Not sure which treatment is right for you?

Book a consultation with Dr. Vipin Reddy and get a personalised treatment plan.

WhatsApp Book Now Directions

Language